Summary
The state is receiving a second payment from drug manufacturer Bristol-Myers Squibb as part of a settlement over the anti-anxiety drug BuSpar.
The Utah Attorney General's Office announced Friday that the most recent payment of $565,192 will be divided between the University of Utah Medical Plan, the state Medicaid office, the Utah Developmental Center, Utah State Hospital, the Public Employees Health Program and the Attorney General Antitrust Litigation Fund.See the full content of this document
Extract
State Gets Funds From Drugmaker
Last July, 305 ...
See the full content of this document
Sponsored links
